» Articles » PMID: 24678734

Research Resource: EPSLiM: Ensemble Predictor for Short Linear Motifs in Nuclear Hormone Receptors

Overview
Journal Mol Endocrinol
Date 2014 Apr 1
PMID 24678734
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Nuclear receptors (NRs) are a superfamily of transcription factors central to regulating many biological processes, including cell growth, death, metabolism, and immune responses. NR-mediated gene expression can be modulated by coactivators and corepressors through direct physical interaction or protein complexes with functional domains in NRs. One class of these domains includes short linear motifs (SLiMs), which facilitate protein-protein interactions, phosphorylation, and ligand binding primarily in the intrinsically disordered regions (IDRs) of proteins. Across all proteins, the number of known SLiMs is limited due to the difficulty in studying IDRs experimentally. Computational tools provide a systematic and data-driven approach for predicting functional motifs that can be used to prioritize experimental efforts. Accordingly, several tools have been developed based on sequence conservation or biophysical features; however, discrepancies in predictions make it difficult to determine the true candidate SLiMs. In this work, we present the ensemble predictor for short linear motifs (EPSLiM), a novel strategy to prioritize the residues that are most likely to be SLiMs in IDRs. EPSLiM applies a generalized linear model to integrate predictions from individual methodologies. We show that EPSLiM outperforms individual predictors, and we apply our method to NRs. The androgen receptor is an example with an N-terminal domain of 559 disordered amino acids that contains several validated SLiMs important for transcriptional activation. We use the androgen receptor to illustrate the predictive performance of EPSLiM and make the results of all human and mouse NRs publically available through the web service http://epslim.bwh.harvard.edu.

Citing Articles

Investigating the disordered regions (MoRFs, SLiMs and LCRs) and functions of mimicry proteins/peptides in silico.

Garg A, Dabburu G, Singhal N, Kumar M PLoS One. 2022; 17(4):e0265657.

PMID: 35421114 PMC: 9009644. DOI: 10.1371/journal.pone.0265657.


Quarterly intrinsic disorder digest (April-May-June, 2014).

DeForte S, Uversky V Intrinsically Disord Proteins. 2017; 5(1):e1287505.

PMID: 28321370 PMC: 5345852. DOI: 10.1080/21690707.2017.1287505.


Control of steroid receptor dynamics and function by genomic actions of the cochaperones p23 and Bag-1L.

Cato L, Neeb A, Brown M, Cato A Nucl Recept Signal. 2014; 12:e005.

PMID: 25422595 PMC: 4242288. DOI: 10.1621/nrs.12005.

References
1.
Henikoff S, Henikoff J . Amino acid substitution matrices from protein blocks. Proc Natl Acad Sci U S A. 1992; 89(22):10915-9. PMC: 50453. DOI: 10.1073/pnas.89.22.10915. View

2.
Sadar M . Small molecule inhibitors targeting the "achilles' heel" of androgen receptor activity. Cancer Res. 2011; 71(4):1208-13. PMC: 3132148. DOI: 10.1158/0008-5472.CAN_10-3398. View

3.
Owen G, Zelent A . Origins and evolutionary diversification of the nuclear receptor superfamily. Cell Mol Life Sci. 2000; 57(5):809-27. PMC: 11147046. DOI: 10.1007/s000180050043. View

4.
Kumar R, Thompson E . The structure of the nuclear hormone receptors. Steroids. 1999; 64(5):310-9. DOI: 10.1016/s0039-128x(99)00014-8. View

5.
He B, Kemppainen J, Wilson E . FXXLF and WXXLF sequences mediate the NH2-terminal interaction with the ligand binding domain of the androgen receptor. J Biol Chem. 2000; 275(30):22986-94. DOI: 10.1074/jbc.M002807200. View